Mindset Pharma Inc.

OTCPK:MSST.F Stock Report

Market Cap: US$54.0m

Mindset Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

James Lanthier

Chief executive officer

CA$783.8k

Total compensation

CEO salary percentage28.7%
CEO tenureno data
CEO ownership2.7%
Management average tenureno data
Board average tenure3.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has James Lanthier's remuneration changed compared to Mindset Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-CA$6m

Dec 31 2022n/an/a

-CA$5m

Sep 30 2022n/an/a

-CA$9m

Jun 30 2022CA$784kCA$225k

-CA$17m

Mar 31 2022n/an/a

-CA$21m

Dec 31 2021n/an/a

-CA$21m

Sep 30 2021n/an/a

-CA$16m

Jun 30 2021CA$477kCA$179k

-CA$12m

Mar 31 2021n/an/a

-CA$7m

Jun 30 2020CA$85kCA$33k

-CA$643k

Compensation vs Market: James's total compensation ($USD565.03K) is about average for companies of similar size in the US market ($USD740.57K).

Compensation vs Earnings: James's compensation has increased whilst the company is unprofitable.

CEO

James Lanthier (48 yo)

no data

Tenure

CA$783,754

Compensation

Mr. James Andre-Charles Lanthier serves as Chief Executive Officer of Mindset Pharma Inc. He served as Chief Executive Officer, President and Director of Magnolia Colombia Ltd. since October 1, 2018 until...

Board Members

NamePositionTenureCompensationOwnership
Joseph Araujo
Chief Scientific Officer3.1yrsCA$833.75k0.089%
$ 48.0k
Abdelmalik Slassi
Senior VP of Innovation & Member of Scientific Advisory Boardno dataCA$918.75k1.5%
$ 812.8k
James Passin
Independent Director3.1yrsCA$213.50k3.01%
$ 1.6m
Richard Patricio
Independent Chairman3.1yrsCA$917.51k3.8%
$ 2.1m
Philip Williams
Independent Director3.1yrsCA$213.50k2.7%
$ 1.5m
Joseph Gabriele
Member of Scientific Advisory Board2.6yrsno datano data
Michael Rogawski
Member of Scientific Advisory Boardno datano datano data
Ishrat Husain
Member of Scientific Advisory Board2.3yrsno datano data
Ian Dean
Former Director of Preclinical & Member of Scientific Advisory Boardno datano datano data
Ali Kandil
Member of Scientific Advisory Boardno datano datano data

3.1yrs

Average Tenure

49yo

Average Age

Experienced Board: MSST.F's board of directors are considered experienced (3.1 years average tenure).